364 related articles for article (PubMed ID: 17471240)
1. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
[TBL] [Abstract][Full Text] [Related]
5. Growth regulation of gastric epithelial cells by Runx3.
Fukamachi H; Ito K
Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
[TBL] [Abstract][Full Text] [Related]
6. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
8. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium.
Saeki N; Usui T; Aoyagi K; Kim DH; Sato M; Mabuchi T; Yanagihara K; Ogawa K; Sakamoto H; Yoshida T; Sasaki H
Genes Chromosomes Cancer; 2009 Mar; 48(3):261-71. PubMed ID: 19051310
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1.
Nagahama Y; Ishimaru M; Osaki M; Inoue T; Maeda A; Nakada C; Moriyama M; Sato K; Oshimura M; Ito H
Cancer Sci; 2008 Jan; 99(1):23-30. PubMed ID: 17956589
[TBL] [Abstract][Full Text] [Related]
10. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
12. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y
Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
[TBL] [Abstract][Full Text] [Related]
16. Spreading of methylation within RUNX3 CpG island in gastric cancer.
Homma N; Tamura G; Honda T; Matsumoto Y; Nishizuka S; Kawata S; Motoyama T
Cancer Sci; 2006 Jan; 97(1):51-6. PubMed ID: 16367921
[TBL] [Abstract][Full Text] [Related]
17. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
19. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
20. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Osaki M; Moriyama M; Adachi K; Nakada C; Takeda A; Inoue Y; Adachi H; Sato K; Oshimura M; Ito H
Eur J Clin Invest; 2004 Sep; 34(9):605-12. PubMed ID: 15379759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
